LOREAL_Registration_Document_2017

6 Stock Market Information Share capital LONG-TERM INCENTIVE PLANS *

Existing conditional grant of shares at 31 December 2017 6.4.3.4. Date of authorisation by the Extraordinary General Meeting 26.04.2013 22.04.2015

20.04.2016

20.04.2016

Date of grant by the Board of Directors

17.04.2014

22.04.2015

20.04.2016

20.04.2017

Total number of shares conditionally granted Of which the ten employees other than executive officers granted the largest number of shares  (1)

1,068,565

860,150

906,100

906,000

153,400

126,100

128,600

137,600

Number of beneficiaries Performance conditions

1,978

1,943

2,079

2,038

50% growth in comparable cosmetics sales as compared to that of a panel of competitors  (2) s 50% growth in the L’Oréal Group’s consolidated operating profit s

Date of final vesting for French tax residents at the date of grant Date of final vesting for non-French tax residents at the date of grant End of the waiting period for French tax residents at the date of grant

17.04.2018

22.04.2019

20.04.2020

20.04.2021

17.04.2018

22.04.2019

20.04.2020

20.04.2021

17.04.2020

22.04.2021

N/A

N/A

Employees who are not executive officers of L’Oréal or employees of companies included within the scope of the grant of shares. (1) For the 2014 plan , the panel consists of the following companies: Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, (2) Revlon, Elizabeth Arden. For the 2015, 2016 and 2017 plans , the panel consists of the following companies: Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, Coty.

Accordingly, the beneficiaries who fulfil the conditions under the plan on 17 April 2018 and, in particular, the condition of presence in the Company, will receive all the shares that were granted to them. For information purposes, 40,000 shares were granted to the executive officer.

Shares definitively invested under the 6.4.3.5. 17 April 2014 ACAs plan The Board of Directors recorded at its meeting on 8 February 2018 that the performance levels achieved during the three years taken into consideration within the scope of the 17 April 2014 plan, namely 2015, 2016 and 2017, exceeded the levels set for the grant of all the shares (ACAs).

TABLE MONITORING THE PERFORMANCE CONDITIONS OF THE ACAS PLAN OF 17 APRIL 2014

Arithmetic average of performances for FY 2015, 2016 and 2017

ACAs plan of 17 April 2014

2015

2016

2017

+0.8 point (+4.1%/+3.3%) +12.80% (3,890.7/4,387.7)

+1.2 points (+ 4.9%/+ 3.7%) +3.5% (4,387.7/4,539.9)

+0.2 point** (+4.8%/+4.6%)** +3.0% (4,539.9/4,676.3)

50% growth in comparable cosmetics sales compared to a panel of competitors*

+0.73 point**

50% growth in the Group’s operating profit

+6.43%

Panel of competitors: Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, Revlon and Elizabeth Arden. Estimates before * Revlon publication. Estimates before Revlon publication. **

REGISTRATION DOCUMENT / L'ORÉAL 2017

332